Jump to navigation
More than two dozen UArizona students have been offered prestigious graduate fellowships totaling nearly $1.2 million. The awards come from the National Science Foundation, U.S. Department of Education, NASA, National Institutes of Health and other organizations.
The Wildcat Writers program brings together teachers and students from UArizona and local high schools to work on shared writing projects. The community-based education program recently celebrated its 20th anniversary.
Michael Tubbs was 26 years old when he was elected mayor of Stockton, California, in 2016, making him the youngest mayor of a major American city and Stockton's first African American mayor. Tubbs will give the keynote address at the university's Commencement ceremony on May 12.
UArizona researchers are forecasting nine hurricanes this year, five of which are expected to be major. Since 2014, hurricane activity has been accurately predicted by a model created by UArizona professor Xubin Zeng and his former graduate student Kyle Davis.
UArizona inventors were issued 92 patents in 2022 for innovations that included a technique for imaging cancer cells, a wearable 3D augmented reality display and an antioxidant sunscreen.
U.S. News & World Report once again ranked the University of Arizona's management information systems program No. 1 among public universities in its 2023 Best Graduate Schools list.
Price Fishback, Takeshi Inomata, Chris Segrin, Kathy Short and Todd Vanderah are UArizona's newest Regents Professors. The university's highest faculty rank honors exceptional achievements that merit national and international recognition.
UArizona Health Sciences is uniquely poised to help address Arizona's long-term health care needs, President Robert C. Robbins said in a presentation to the Arizona Board of Regents.
On April 23, 1923, the university celebrated a new, 36-inch telescope that would kick off major astronomical research. Steward Observatory will be rededicated this weekend in honor of its 100-year anniversary.
Hsp90-inhibitor drugs in the spinal cord are showing promise as potential pain therapeutics, finds a new study by University of Arizona Health Sciences researchers.
